Microfluidic apparatus and methods of use thereof
Apparatuses and methods are described herein for processing polynucleotides in a sealed path environment. The apparatuses include optical sensors to monitor operations and to track material usage for good manufacturing practice.
1. A microfluidic apparatus for forming a therapeutic polynucleotide, the apparatus comprising:
(a) at least one microfluidic path device;
(b) a plurality of fluid containers;
(c) a seating mount removably holding the at least one microfluidic path device;
(d) a plurality of pressure lines, each pressure line being operable to provide pneumatic pressure to the at least one microfluidic path device held in the seating mount;
(e) a plurality of fluidic lines coupled with the plurality of fluid containers, each fluidic line being operable to provide fluid to the at least one microfluidic path device held in the seating mount such that the plurality of fluidic lines, the plurality of fluid containers, and the at least one microfluidic path device collectively form a closed fluid path so that fluid within the closed fluid path is isolated from atmosphere; and
(f) a controller comprising one or more processors, the one or more processors programmed to:
(i) control application of pressure through the pressure lines to thereby apply pneumatic pressure to the at least one microfluidic path device held in the seating mount, and
(ii) control communication of one or more fluids through the plurality of fluidic lines to thereby provide one or more of the following:
(A) synthesis of a synthetic template in the at least one microfluidic path device held in the seating mount,
(B) an in vitro transcription (IVT) reaction using the template to form a therapeutic polynucleotide in the at least one microfluidic path device held in the seating mount, or
(C) purify the therapeutic polynucleotide in the at least one microfluidic path device held in the seating mount.
2. The microfluidic apparatus of claim 1 , the plurality of fluid containers comprising a plurality of vials.
3. The microfluidic apparatus of claim 1 , further comprising a plurality of sensors configured to monitor fluid levels within the plurality of fluid containers.
4. The microfluidic apparatus of claim 3 , the plurality of sensors including one or more optical sensors.
5. The microfluidic apparatus of claim 1 , at least one fluidic line of the plurality of fluidic lines being configured to be biased against the at least one microfluidic path device held in the seating mount.
6. The microfluidic apparatus of claim 1 , at least one pressure line of the plurality of pressure lines being configured to be biased against the at least one microfluidic path device held in the seating mount.
7. The microfluidic apparatus of claim 1 , further comprising one or more optical sensors positionable to optically sense one or more regions of the at least one microfluidic path device held in the seating mount.
8. The microfluidic apparatus of claim 1 , further comprising a fluid interface assembly configured to hold the plurality of fluidic lines.
9. The microfluidic apparatus of claim 8 , further comprising at least one alignment pin configured to align the fluid interface assembly with the seating mount.
10. The microfluidic apparatus of claim 1 , further comprising one or more alignment features configured to align the at least one microfluidic path device in the seating mount.
11. The microfluidic apparatus of claim 1 , further comprising an enclosure having a cover, configured to maintain sterility of the microfluidic apparatus during operation of the microfluidic apparatus.
12. The microfluidic apparatus of claim 1 , further comprising a signal detector configured to detect a signal from within the at least one microfluidic path device held in the seating mount.
13. The microfluidic apparatus of claim 12 , wherein the signal includes one or more of: a visible signal, a fluorescent signal, a UV absorbance signal, or an IR absorbance signal.
14. The microfluidic apparatus of claim 12 , wherein the signal detector is configured to measure a nanoparticle size distribution.
15. The microfluidic apparatus of claim 1 , the seating mount including a generally square-shaped annular recess for supporting an outer peripheral region of the at least one microfluidic path device.
16. The microfluidic apparatus of claim 1 , further comprising a plurality of springs extending downwardly relative to the seating mount.
17. The microfluidic apparatus of claim 16 , the plurality of springs being configured to bias the seating mount.
18. A microfluidic apparatus for forming a therapeutic polynucleotide, the apparatus comprising:
(a) a seating mount for removably holding a microfluidic path device;
(b) a plurality of pressure lines, each pressure line being operable to provide pneumatic pressure to a microfluidic path device held in the seating mount;
(c) a plurality of fluidic lines, each fluidic line being operable to provide fluid to a microfluidic path device held in the seating mount to form a closed fluid path;
(d) a controller comprising one or more processors, the one or more processors programmed to:
(i) control application of pressure through the pressure lines to thereby apply pneumatic pressure to a microfluidic path device held in the seating mount, and
(ii) control communication of one or more fluids through the plurality of fluidic lines to thereby provide one or more of the following:
(A) synthesis of a synthetic template in one or more microfluidic path devices held in the seating mount,
(B) an in vitro transcription (IVT) reaction using the template to form a therapeutic polynucleotide in one or more microfluidic path devices held in the seating mount, or
(C) purify the therapeutic polynucleotide in one or more microfluidic path devices held in the seating mount;
(e) one or more optical sensors positionable to optically sense one or more regions of a microfluidic path device held in the seating mount; and
(f) an optical sensor drive operable to move at least one of the one or more optical sensors relative to a microfluidic path device held in the seating mount.
19. A microfluidic apparatus for forming a therapeutic polynucleotide, the apparatus comprising:
(a) a seating mount for removably holding a microfluidic path device;
(b) a fluid interface assembly having a central opening, the fluid interface assembly comprising:
(i) a plurality of pressure lines, each pressure line being operable to provide pneumatic pressure to a microfluidic path device held in the seating mount, and
(ii) a plurality of fluidic lines, each fluidic line being operable to provide fluid to a microfluidic path device held in the seating mount to form a closed fluid path; and
(c) a controller comprising one or more processors, the one or more processors programmed to:
(i) control application of pressure through the pressure lines to thereby apply pneumatic pressure to a microfluidic path device held in the seating mount, and
(ii) control communication of one or more fluids through the plurality of fluidic lines to thereby provide one or more of the following:
(A) synthesis of a synthetic template in one or more microfluidic path devices held in the seating mount,
(B) an in vitro transcription (IVT) reaction using the template to form a therapeutic polynucleotide in one or more microfluidic path devices held in the seating mount, or
(C) purify the therapeutic polynucleotide in one or more microfluidic path devices held in the seating mount;
each pressure line of the plurality of pressure lines and each fluidic line of the plurality of fluidic lines having a respective sealing end arranged around a periphery of the central opening.
20. The microfluidic apparatus of claim 19 , the fluid interface assembly including a plurality of sealing end exit points arranged around the periphery of the central opening, each fluidic line of the plurality of fluidic lines extending at least partially through a corresponding sealing end exit point of the plurality of sealing end exit points.